AbstractThe V3 loop of HIV-1 gp120 is considered occluded on many primary viruses. However, virus sensitivity to neutralization by different V3 mAbs often varies, indicating that access to V3 is not restricted equally for all antibodies. Here, we have sought to gain a better understanding of these restrictions by determining the neutralizing activities of 7 V3 mAbs (19b, 39F, CO11, F2A3, F530, LA21, and LE311) against 15 subtype B primary isolates and relating these activities to the fine specificity of the mAbs. Not surprisingly, we found that most mAbs neutralized the same 2–3 viruses, with only mAb F530 able to neutralize 2 additional viruses not neutralized by the other mAbs. Epitope mapping revealed that positively-charged residues in ...
The external subunit of the human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env),...
The targets of broadly cross-neutralizing (BCN) antibodies are of great interest in the HIV vaccine ...
AbstractThe HIV-1 gp120 V3 loop is a potent inducer of neutralizing antibodies for T cell line adapt...
AbstractThe identification of cross-neutralizing antibodies to HIV-1 is important for designing anti...
AbstractOne approach to the development of an HIV vaccine is to design a protein template which can ...
AbstractRabbits were immunized with a novel regimen designed to focus the immune response on a singl...
SummaryHuman monoclonal antibodies 447-52D and 537-10D, both coded by the VH3 gene and specific for ...
AbstractAntibody B4e8 exhibits modest cross-neutralizing activity, with preference for HIV subtype B...
The V3 loop of the HIV-1 envelope (Env) glycoprotein gp120 was identified as the "principal neutrali...
AbstractAchieving humoral immunity against human immunodeficiency virus (HIV) is a major obstacle in...
Developing HIV-1 vaccines that trigger broadly neutralizing antibodies (bnAbs) is a priority as bnAb...
AbstractThe detailed interactions between antibodies and the HIV-1 envelope protein that lead to neu...
The C3-V4 region is a major target of autologous neutralizing antibodies in HIV-1 subtype C infectio...
The V3 loop of HIV-1 gp120 is an immunodominant region targeted by neutralizing antibodies (nAbs). D...
The early autologous neutralizing antibody response in human immunodeficiency virus type 1 (HIV-1) s...
The external subunit of the human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env),...
The targets of broadly cross-neutralizing (BCN) antibodies are of great interest in the HIV vaccine ...
AbstractThe HIV-1 gp120 V3 loop is a potent inducer of neutralizing antibodies for T cell line adapt...
AbstractThe identification of cross-neutralizing antibodies to HIV-1 is important for designing anti...
AbstractOne approach to the development of an HIV vaccine is to design a protein template which can ...
AbstractRabbits were immunized with a novel regimen designed to focus the immune response on a singl...
SummaryHuman monoclonal antibodies 447-52D and 537-10D, both coded by the VH3 gene and specific for ...
AbstractAntibody B4e8 exhibits modest cross-neutralizing activity, with preference for HIV subtype B...
The V3 loop of the HIV-1 envelope (Env) glycoprotein gp120 was identified as the "principal neutrali...
AbstractAchieving humoral immunity against human immunodeficiency virus (HIV) is a major obstacle in...
Developing HIV-1 vaccines that trigger broadly neutralizing antibodies (bnAbs) is a priority as bnAb...
AbstractThe detailed interactions between antibodies and the HIV-1 envelope protein that lead to neu...
The C3-V4 region is a major target of autologous neutralizing antibodies in HIV-1 subtype C infectio...
The V3 loop of HIV-1 gp120 is an immunodominant region targeted by neutralizing antibodies (nAbs). D...
The early autologous neutralizing antibody response in human immunodeficiency virus type 1 (HIV-1) s...
The external subunit of the human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env),...
The targets of broadly cross-neutralizing (BCN) antibodies are of great interest in the HIV vaccine ...
AbstractThe HIV-1 gp120 V3 loop is a potent inducer of neutralizing antibodies for T cell line adapt...